Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib

INTRODUCTION: Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is an autoinflammatory disorder without standardized treatment. Janus kinase (JAK) inhibitors can block a range of cytokines and might possess significant anti-inflammatory activity. Here, we report the first case...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiao, Zhao, Yumo, Li, Chen, Luo, Yaping, Hao, Weixin, Zhang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024477/
https://www.ncbi.nlm.nih.gov/pubmed/29924019
http://dx.doi.org/10.1097/MD.0000000000011149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024477/
https://www.ncbi.nlm.nih.gov/pubmed/29924019
http://dx.doi.org/10.1097/MD.0000000000011149

Ejemplares similares